Annual Congress: Hematologic Malignancies
The NCCN 2022 Annual Congress: Hematologic Malignancies™ was held on October 14 – 15, 2022 in New York City and virtually.
Save the dates! The NCCN 2023 Annual Congress: Hematologic Malignancies™ will take place Friday, September 22, 2023 – Saturday, September 23, 2023 at the Hilton San Francisco Union Square in San Francisco, California.
Continuing Education
Congress attendees will have the opportunity to view sessions on-demand and access materials in the Digitell platform through December 2022.
Recorded sessions will be available in the NCCN Continuing Education Portal, education.nccn.org, later this year.
Chaired by Andrew D. Zelenetz, MD, PhD, from Memorial Sloan Kettering Cancer Center, the Congress featured panel discussions with world-renowned experts, interactive presentations, and challenging patient cases that highlight recent updates to the NCCN Guidelines®, new and emerging therapeutic agents, and practical management strategies for patients with hematologic malignancies. The agenda included topics designed to meet the educational needs of oncologists, hematologists, nurse practitioners, nurses, pharmacists, physician assistants, and other health care professionals who manage patients with hematologic malignancies.
This program is approved for AMA PRA Category 1 Credit™ and ABIM, ABPath, and ABMS MOC for physicians and is also certified for credit for nurses, pharmacists, and other oncology professionals.
- AstraZeneca
- GlaxoSmithKline
- Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
- Kite, A Gilead Company
- Lilly
- Novartis
- Seagen
- Taiho Oncology, Inc.
- AbbVie
- Bristol Myers Squibb
- Daiichi Sankyo
- Incyte
- Merck & Co., Inc.
This program is supported by independent medical education grants from:
- Jazz Pharmaceuticals
- Pfizer Inc
This activity is supported by educational funding provided by Amgen.
This activity is supported by a medical education grant from Karyopharm Therapeutics.
Exhibition Hall
Congress attendees can continue to access Virtual Exhibits and the Patient Advocacy Pavilion in the Digitell platform through December 2022.
For exhibitor opportunities, contact Jennifer Tredwell, Vice President, Marketing and Communications
2022 Commercial Sponsors
Gold Level Sponsors
BeiGene
Incyte Corporation
Janssen Oncology
Silver Level Sponsor
Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc.
Bronze Level Sponsors
AstellasAstraZeneca
Genentech
Jazz Pharmaceuticals
Karyopharm Therapeutics, Inc.
Patient Advocacy Pavilion Sponsors
Ruby
Pharmacyclics LLC., an AbbVie Company
Emerald
AstraZeneca
BeiGene
Coherus BioSciences
Eisai Inc.
Gilead & Kite Oncology
Incyte
Janssen Oncology
Karyopharm Therapeutics, Inc.
Topaz
AbbVie
Amerisource Bergen
GSK
Heron Therapeutics, Inc.
Lantheus
Jade
Related Program
The NCCN 2022 Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ was held on Saturday, October 15, 2022 in New York City and virtually.
Save the date! The NCCN 2023 Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ will take place Friday, September 22, 2023 at the Hilton San Francisco Union Square in San Francisco, California.
Forum attendees will have access to sessions and materials in the Digitell platform through December 2022.
Recorded session will be posted on the NCCN Continuing Education Portal, education.nccn.org, later this year.